Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Polycystic Ovary Syndrome × Surveys and Questionnaires × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 49 Neoplasms 24 Prostatic Neoplasms 15 Lung Neoplasms 13 Head and Neck Neoplasms 13 Colorectal Neoplasms 12 Motor Activity 11 Gastrointestinal Neoplasms 9 Neoplasm Metastasis 6 Lymphoma 6 Endometrial Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Uterine Cervical Neoplasms 5 Pain 5 Ovarian Neoplasms 5 Anxiety Disorders 5 Sarcoma 4 Rectal Neoplasms 4 Multiple Myeloma 4 Melanoma 4 Hematologic Neoplasms 4 Fatigue 4 Esophageal Neoplasms 4 Stomach Neoplasms 3 Smoking Cessation 3 Recurrence 3 Papillomavirus Infections 3 Pancreatic Neoplasms 3 Malignant Neoplasms of Independent (Primary) Multiple Sites 3 Leukemia 3

Interventions

Metformin 46 Inositol 20 Clomiphene 16 Letrozole 15 Exercise 11 Folic Acid 9 Caloric Restriction 9 High-Intensity Interval Training 8 Ethinyl Estradiol 8 Progesterone 7 Estradiol 6 Diet 6 drospirenone 5 drospirenone and ethinyl estradiol combination 4 Tablets 4 In Vitro Oocyte Maturation Techniques 4 Diet, Mediterranean 4 Cyproterone Acetate 4 Control Groups 4 Berberine 4 Acupuncture Therapy 4 Triptorelin Pamoate 3 Thioctic Acid 3 Spironolactone 3 Resistance Training 3 Medroxyprogesterone Acetate 3 Flutamide 3 Estrogens 3 Dydrogesterone 3 Diet Therapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07274202 2025-12-10

QolART

Universitair Ziekenhuis Brussel

Phase NA Not yet recruiting

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡